Nasal version of AstraZeneca SARS-CoV-2 vaccine prevents infection in animal models

By | August 4, 2021
Scientists evaluate the use of ChAdOx1 nCoV-19 as a potential intranasal (IN) vaccine candidate in hamster and rhesus macaque models.